生物技术与制药领域的最新动态
Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe - Business Wire
Agrigenomics arrays and consortia | Collaborating with experts - Illumina
Comparative analysis of illumina and oxford nanopore sequencing platforms for 16S rRNA profiling of respiratory microbial communities | Scientific Reports - Nature
Lonza’s Synaffix Collaborates with Qurient Therapeutics on Dual-Payload ADC Development - GEN - Genetic Engineering and Biotechnology News
Lonza’s Synaffix and Qurient team up on dual-payload ADC - The Pharma Letter
RION engages Lonza to scale manufacturing exosome based therapeutics - News-Medical
Roche, Novartis underline U.S. plans after Trump pharma tariff announcement - Reuters
Leveraging illumina iSeq100 for whole genome sequencing of Salmonella Typhi for a resource-limited setting - Nature
Lonza's Synaffix Collaborates with Qurient Therapeutics to Enable Development of Dual-Payload ADC - Yahoo Finance
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial - CNBC
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics - Business Wire
RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing - Contract Pharma
Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics - GEN - Genetic Engineering and Biotechnology News
Geriatrician Roche appointed Professor Emeritus of Internal Medicine - UT Southwestern Medical Center
Roche pushes a novel myeloma target | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Roche's 'top three' obesity ambition not reliant on developing one megablockbuster - Fierce Biotech
Roche looks earlier with divarasib | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Illumina to develop KRAS companion diagnostics with multiple pharma partners - FirstWord Pharma
Illumina advances personalized cancer care with new pharma development partnerships - PR Newswire
Thermo Fisher Scientific’s Valuation: Assessing New Launches and Upgraded Outlook - Yahoo Finance